[Federal Register Volume 84, Number 74 (Wednesday, April 17, 2019)]
[Notices]
[Pages 16035-16036]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07661]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1136]


Certain Obstructive Sleep Apnea Treatment Mask Systems and 
Components Thereof; Termination of Investigation on the Basis of 
Settlement

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review the presiding administrative 
law judge's (``ALJ'') initial determination (``ID'') (Order No. 10), 
granting a joint motion to terminate the investigation on the basis of 
settlement. The investigation is terminated.

FOR FURTHER INFORMATION CONTACT: Sidney A. Rosenzweig, Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 708-2532. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW, Washington, DC 20436, 
telephone (202) 205-2000. General

[[Page 16036]]

information concerning the Commission may also be obtained by accessing 
its internet server at https://www.usitc.gov. The public record for 
this investigation may be viewed on the Commission's electronic docket 
(EDIS) at https://edis.usitc.gov. Hearing-impaired persons are advised 
that information on this matter can be obtained by contacting the 
Commission TDD terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on October 12, 2018, based on a complaint filed by Fisher & Paykel 
Healthcare Limited of Auckland, New Zealand (``F&P''). 83 FR 51705 
(Oct. 12, 2018). The complaint alleged violations of section 337 of the 
Tariff Act of 1930, as amended, 19 U.S.C. 1337 in the importation, sale 
for importation, and the sale within the United States after 
importation of certain obstructive sleep apnea treatment mask systems 
and components thereof by reason of the infringement of certain claims 
of U.S. Patent Nos. 9,333,315; 9,517,317; 9,539,405; 9,907,925; and 
9,974,914. The notice of investigation named as respondents ResMed 
Corp. and ResMed Inc., both of San Diego, California; and ResMed 
Limited of Bella Vista, Australia (collectively, ``ResMed''). The 
Office of Unfair Import Investigations did not participate in this 
investigation.
    On February 22, 2019, the parties jointly moved to terminate the 
investigation based upon settlement.
    On March 18, 2019, the presiding ALJ granted the motion as the 
subject ID (Order No. 10). The ID finds that the motion complies with 
Commission Rule 210.21, see 19 CFR 210.21(a)-(b), and that the 
settlement agreement will not adversely affect the public interest, 19 
CFR 210.50(b)(2). ID at 1-2.

    No petitions for review of the ID were filed.
    The Commission has determined not to review the ID.

    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: April 11, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019-07661 Filed 4-16-19; 8:45 am]
 BILLING CODE 7020-02-P